CNCE Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (4 bal. 2024 @ 23:00):

Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases...

Stats
Dzisiejszy wolumen	10.73M
Średni wolumen	0.00
Kapitalizacja rynkowa	401.95M
EPS	$0 ( 2023-08-02 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.64
ATR14	$0.231 (2.76%)

Insider Trading

Date	Person	Action	Amount	type
2023-03-06	Van Heek Christi	Sell	25 651	Common Stock
2023-03-06	Van Heek Christi	Sell	16 400	Common Stock
2023-03-06	Van Heek Christi	Sell	25 000	Stock Option (Right to Buy)
2023-03-06	Van Heek Christi	Sell	10 000	Stock Option (Right to Buy)
2023-03-06	Van Heek Christi	Sell	10 000	Stock Option (Right to Buy)

INSIDER POWER
-100.00
Last 100 transactions
Buy: 0 \| Sell: 4 463 235

Wolumen Korelacja

Długi: 0.24 (neutral)

Krótki: -0.57 (weak negative)

Signal:(66.67) Neutral

Concert Pharmaceuticals Korelacja

10 Najbardziej pozytywne korelacje
NNOX	0.949
NERV	0.942
TYHT	0.942
MESA	0.94
RVNC	0.935
IDYA	0.932
PIRS	0.929
CELH	0.928
LIXT	0.928
MBINO	0.927

10 Najbardziej negatywne korelacje
TWKS	-0.963
FNWB	-0.958
HMST	-0.951
TCPC	-0.949
UPLD	-0.948
INFI	-0.942
EYE	-0.941
VNET	-0.94
SABRP	-0.939
TBNK	-0.938

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Concert Pharmaceuticals Korelacja - Waluta/Towar

0.81
( strong )

0.84
( strong )

-0.59
( weak negative )

0.62
( weak )

0.13
( neutral )

-0.41
( neutral )

Concert Pharmaceuticals Finanse

Annual	2021
Przychody:	$32 578.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-0.00233

FY	2021
Przychody:	$32 578.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-0.00233

FY	2020
Przychody:	$7.90M
Zysk brutto:	$7 902.00 (0.10 %)
EPS:	$-2.40

FY	2019
Przychody:	$1.08M
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-3.29

Financial Reports:

No articles found.

Concert Pharmaceuticals

Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has strategic collaborations with Avanir Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Cipla Technologies; and Processa Pharmaceuticals. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.